Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low‐ and Middle‐Income Countries
Pediatric Blood & Cancer · 2026-05 · 73 (5)
DOI: 10.1002/1545-5017.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 15.03.2026. Verfasst von Kenneth M Busby und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Developing Countries, Neoplasms, Medical Oncology. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIH Cancer Control Education.
Abstract (Originalsprache)
Background
Inaccurate or imprecise diagnosis is a major contributor to treatment failure for children with cancer in low‐ and middle‐income countries (LMICs). Sequencing‐based diagnostic testing presents an opportunity to overcome diagnostic deficiencies. It is important to identify facilitators and barriers which are common to the implementation of sequencing‐based diagnostics in LMICs. Procedure Pediatric oncology research collaborators at six hospitals in LMICs were invited to participate in the study. Snowball sampling identified additional participants. Thirty‐nine virtual, semi‐structured interviews were conducted using interview guides informed by the Consolidated Framework for Implementation Research (CFIR) with suggested adaptations for LMICs. Rapid qualitative analysis was conducted to identify facilitators and barriers to the implementation of diagnostic sequencing for pediatric cancers. Barriers were then matched with expert recommendation for implementation change (ERIC) strategies.
Results
Implementation facilitators and barriers were organized by CFIR construct. Predominant facilitators were relative advantage, culture, collective efficacy, self‐efficacy, patient needs and resources, leadership engagement, knowledge and beliefs, tension for change, monitoring services for action, and implementation climate. Key barriers to implementation were cost, available resources, resource continuity, engaging participants, and resource source.
Conclusions
Participants communicated that the lack of diagnostic classification for pediatric cancer in LMICs is a common key limitation to current cancer care. They described considerable motivating strengths to leverage toward this goal of developing sequencing‐based diagnostic testing capacity. Resource availability, continuity, and sustainability are current barriers that must be addressed. Our data highlight the urgent need for creative global implementation partnerships as many centers in LMICs are poised to advance novel diagnostic solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
- College of Arts and Science, University of North Carolina, Chapel Hill, North Carolina, USA.
- Indus Hospital, Karachi, Pakistan.
- Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
- School of Medicine, Francisco Marroquín University, Guatemala City, Guatemala.
ORCID-Profile: Kenneth M Busby, Rui M Reis, Dylan Graetz, Thomas B Alexander
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- NIH Cancer Control Education
Zitieren
APA
Busby, K. M., Webb, N., Aijaz, J., Antillon-Klussmann, F., Saha, V., Reis, R. M., Tamamyan, G., Alcasabas, P., Cutiongdo-de la Paz, E., Zeal, J., Graetz, D., Bhakta, N., Navas, A., Rubio, S., Rennie, S., Alexander, T. B., & Roberts, M. C. (2026). Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low‐ and Middle‐Income Countries. Pediatric Blood & Cancer, 73(5). https://doi.org/10.1002/1545-5017.70207
Vancouver
Busby KM, Webb N, Aijaz J, Antillon-Klussmann F, Saha V, Reis RM, et al. Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low‐ and Middle‐Income Countries. Pediatric Blood & Cancer. 2026;73(5). doi:10.1002/1545-5017.70207
BibTeX
@article{Busby2026,
author = {Busby, Kenneth M and Webb, Nathaniel and Aijaz, Javeria and Antillon-Klussmann, Federico and Saha, Vaskar and Reis, Rui M and Tamamyan, Gevorg and Alcasabas, Patricia and Cutiongdo-de la Paz, Eva and Zeal, Jamie and Graetz, Dylan and Bhakta, Nickhill and Navas, Angelo and Rubio, Samantha and Rennie, Stuart and Alexander, Thomas B and Roberts, Megan C},
title = {Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low‐ and Middle‐Income Countries},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {5},
doi = {10.1002/1545-5017.70207}
}
EUVIMED